Radiance II

The objective of the RADIANCE II Pivotal study is to demonstrate the effectiveness and safety of the Paradise System in subjects with Stage 2 hypertension on 0-2 medications at the time of consent. Prior to randomization, subjects will be hypertensive in the absence of hypertension medication.
Contact phone
Principal investigator
Joel Cohn, M.D., FACC
Trial Category
Heart & Vascular
Trial SubCategory